Gene-dosage effects in Down syndrome and trisomic mouse models
about
Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 HomologuesRedox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21.Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomyIdentification of dysregulated genes in lymphocytes from children with Down syndrome.Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA spongesOverexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascadeThe cognitive phenotype of Down syndrome: insights from intracellular network analysisAneuploidy: from a physiological mechanism of variance to Down syndrome.What can we learn from study of Alzheimer's disease in patients with Down syndrome for early-onset Alzheimer's disease in the general population?Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic miceThe GIRK2 subunit is involved in IS-like seizures induced by GABA(B) receptor agonists.Impairment of circulating endothelial progenitors in Down syndrome.
P2860
Q27300997-86DC96A8-322B-4DF9-9F2B-B3FE0A525E83Q30367032-6501CE8C-E058-4113-AD2F-C593D434231AQ33236637-C78EF89E-67F9-4F85-96F6-16006853DB9BQ33293466-29A97B22-86DA-413E-83B2-C3E2C0081180Q33324833-4F20730C-0750-43F3-9069-418FEF3A150CQ34229190-394C8240-2259-49F4-86F5-3E7283B6D2B9Q34674349-18B37EB1-6516-4ED8-8776-244CEF3ACEB4Q36371958-33935161-94B4-4C32-AA8D-FDFADB2D85D6Q36525183-68112093-0E57-4BDB-BE62-84AA37DF0D08Q37543845-E4D10CC9-955A-4ECF-A335-FF30383E7E58Q38568871-08FCC92D-EE2C-464C-9BE2-CACCB8D2FF84Q38715222-3E52F318-61A6-454A-A784-8423443493A3Q40880509-C44F2176-D291-45A2-94A9-1ACD0262142BQ42067838-2EDBBADE-5CE3-4AE6-B8CF-DBAE73F0C3B4
P2860
Gene-dosage effects in Down syndrome and trisomic mouse models
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Gene-dosage effects in Down syndrome and trisomic mouse models
@ast
Gene-dosage effects in Down syndrome and trisomic mouse models
@en
Gene-dosage effects in Down syndrome and trisomic mouse models
@en-gb
Gene-dosage effects in Down syndrome and trisomic mouse models
@nl
type
label
Gene-dosage effects in Down syndrome and trisomic mouse models
@ast
Gene-dosage effects in Down syndrome and trisomic mouse models
@en
Gene-dosage effects in Down syndrome and trisomic mouse models
@en-gb
Gene-dosage effects in Down syndrome and trisomic mouse models
@nl
prefLabel
Gene-dosage effects in Down syndrome and trisomic mouse models
@ast
Gene-dosage effects in Down syndrome and trisomic mouse models
@en
Gene-dosage effects in Down syndrome and trisomic mouse models
@en-gb
Gene-dosage effects in Down syndrome and trisomic mouse models
@nl
P2860
P921
P356
P1433
P1476
Gene-dosage effects in Down syndrome and trisomic mouse models
@en
P2093
Katheleen Gardiner
P2860
P2888
P356
10.1186/GB-2004-5-10-244
P407
P577
2004-09-30T00:00:00Z
P5875
P6179
1006159884